The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,810.00
Bid: 1,811.00
Ask: 1,811.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 1,805.00
High: 1,812.50
Low: 1,797.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets in the red with BoE, Fed in focus

Wed, 20th Nov 2013 11:33

- BoE voted unanimously on policy at last meeting- MPC attempts to play down rate-hike fears- Taper in focus ahead of FOMC minutestechMARK 2,627.20 -0.64%FTSE 100 6,670.70 -0.41%FTSE 250 15,181.39 -0.55%UK markets were trading in the red on Wednesday after the Bank of England expressed concerns with the economic recovery and as investors awaited the minutes of the latest Federal Reserve policy meeting. A number of heavyweight stocks were providing a drag on London's FTSE 100 index by midday after going ex-dividend, meaning that from today investors won't be able to get their hands on the companies' latest payouts.It was revealed this morning that the Bank of England's Monetary Policy Committee (MPC) voted unanimously to maintain the Bank Rate at 0.5% and the stock of asset purchases at £375bn at its latest meeting, as expected. However, the MPC attempted to ease fears over a sooner-than-expected tightening in monetary policy as the minutes of the meeting expressed "uncertainties over the durability of the recovery". The central bank reiterated that rates would be kept low until the unemployment rate reaches the 7% threshold, at which point policymakers would then reassess its stance.Analyst Philip Shaw from Investec said that the minutes didn't provide any firm clues to the timing of a possible rate increase. "Rather they conveyed the degree of uncertainty on the committee on the economic outlook and the recovery in productivity, which will be key factors in the monetary policy debate," he said.Meanwhile, the Federal Open Market Committee (FOMC) will release details of its October meeting later this evening as markets wait to hear about the central bank's decision to maintain its stimulus programme last month.However, comments from Fed Chairman Ben Bernanke last night were in focus this morning after he reiterated that any tapering of asset purchases remains dependent on incoming economic data, as he held back from shedding any light on the timetable for an impending withdrawal.Telecom Plus soars after H1 results, acquisitionsUtilities reseller Telecom Plus was a high riser this morning after agreeing to pay £218m to buy back two gas and electricity supply businesses from Npower which it sold in 2006. The announcement came as the firm delivered a 17% increase in revenues in the first half, as profits rose 10.1%.Ex-div stocks were weighing on the FTSE 100 with Vodafone, Tate & Lyle, Next, Carnival and Sainsbury among the stocks trading without the right to their latest payouts.Drinks group Diageo was under the weather after Chief Executive Ivan Menezes was reported as saying that the "uncertain" macro environment will continue to limit sales growth. Sector peer SABMiller was also out of favour this morning.Airline group easyJet was extending gains made yesterday after the company delivered a 51% increase in annual profits and unveiled an unexpected special dividend to shareholders.GlaxoSmithKline rose after completing the partial sale of Aspen Pharmacare, raising gross proceeds of 7.06bn South African rand ($695m).Engineering and construction firm Kentz was higher after being awarded a $190m contract with Qatar Petroleum for services on 775 wells across the Dukhan Oilfield in Qatar, extending the firms' long-standing relationship which started back in 1997.Fund manager Aberdeen rose after analysts at Bank of America Merrill Lynch upgraded their rating on the stock from 'underperform' to 'neutral'. FTSE 100 - RisersAberdeen Asset Management (ADN) 484.90p +2.04%British Sky Broadcasting Group (BSY) 838.50p +1.64%Travis Perkins (TPK) 1,752.00p +1.57%easyJet (EZJ) 1,362.00p +1.26%Pearson (PSON) 1,342.00p +0.98%Johnson Matthey (JMAT) 3,116.00p +0.84%Aviva (AV.) 429.90p +0.68%Rio Tinto (RIO) 3,277.50p +0.57%William Hill (WMH) 363.10p +0.50%Royal Dutch Shell 'B' (RDSB) 2,200.00p +0.46%FTSE 100 - FallersRexam (REX) 488.50p -2.98%Vodafone Group (VOD) 227.15p -2.11%Amec (AMEC) 1,160.00p -2.03%Hammerson (HMSO) 505.00p -1.94%Persimmon (PSN) 1,163.00p -1.86%Melrose Industries (MRO) 298.20p -1.84%Tate & Lyle (TATE) 806.50p -1.77%Bunzl (BNZL) 1,368.00p -1.72%Sainsbury (J) (SBRY) 404.80p -1.68%Vedanta Resources (VED) 955.00p -1.65%FTSE 250 - RisersTelecom Plus (TEP) 1,745.00p +15.79%International Personal Finance (IPF) 591.50p +2.69%Kentz Corporation Ltd. (KENZ) 555.50p +2.49%Lancashire Holdings Limited (LRE) 811.50p +2.40%BH Global Ltd. USD Shares (BHGU) 11.91 +1.79%Rathbone Brothers (RAT) 1,559.00p +1.56%BH Macro Ltd. EUR Shares (BHME) € 20.00 +1.52%NMC Health (NMC) 375.50p +1.49%BH Macro Ltd. USD Shares (BHMU) 19.69 +1.44%BTG (BTG) 446.30p +1.39%FTSE 250 - FallersTalkTalk Telecom Group (TALK) 266.20p -3.55%Centamin (DI) (CEY) 48.19p -3.43%Spirent Communications (SPT) 102.20p -3.31%Bovis Homes Group (BVS) 744.50p -2.93%African Barrick Gold (ABG) 186.40p -2.76%ITE Group (ITE) 304.10p -2.69%Kenmare Resources (KMR) 20.49p -2.66%Wood Group (John) (WG.) 788.50p -2.41%Ashmore Group (ASHM) 378.70p -2.40%Hiscox Ltd (HSX) 662.00p -2.36%BC
More News
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.